Articles

Of a mind to learn and connect

Neuroscience 2010 show aims to stimulate thought and provide networking for some 30,000 neuroscience professionals in sunny San Diego
Written byJeffrey Bouley
| 11 min read

SAN DIEGO—While the 40th annual meeting of the Society for Neuroscience (SfN) being held in mid-November in San Diego won't look much different structurally than last year, there is plenty of new and vibrant scientific content for the expected 30,000-plus attendees to appreciate, according to the event's organizers, including such areas as optogenetics and new understandings of the genetic basis of neurological diseases—not to mention the planned attendance of actress Glenn Close, as well.

The event remains a vital one, this year as with every year, because of the critical need for neuroscientists to trade information effectively, notes Dr. Michael E. Goldberg, president of SfN and David Mahoney Professor of Brain and Behavior in the Departments of Neuroscience, Neurology, Psychiatry and Ophthalmology at the Columbia University College of Physicians and Surgeons.

"The thing about brain research is that it crosses so many disciplines," he notes. "I basically do neurophysiology, but I also use psychology as well because I need psychological and psychiatric techniques to do my work. I do some theoretical modeling, and I have done anatomy in the past. Unlike in many disciplines, which are relatively constrained, neuroscience is this extraordinary swath from molecules to the mind."

There are, for example, researchers focused on neural development, while others are focused on neurochemistry, and research can span the range from neurogenetics to treating the brain as a machine to evaluate the computations it does—Goldberg's own area of interest—and extending that to human disease.

"For this kind of wide-ranging information transfer, we have a huge number of posters—more than 16,000 abstracts this year, and we're expecting 32,000 participants in the meeting," Goldberg says. "Even factoring out a couple thousand vendors, that means about half the scientists coming to this meeting are presenting their own work. As such, scientists going to the meeting will have a huge panoply of things to learn from the fine points of their own field to other areas that might impact on it."

As far as topics that Goldberg finds particularly exciting this year, one that springs to his mind is the emerging field of optogenetics, which combines optical and genetic techniques to probe neural circuits within intact animals, at the millisecond-scale speeds needed to understand how the brain processes information.

"You can deliver a gene into a neuron that then makes a light-sensitive protein, allowing you to use a light source—such as an optical fiber—to gain exquisite control over neural activity," he explains. "It began to see attention a couple years ago and has spread to a lot of different animal models now, from invertebrates to mice, and some people are even using the techniques in monkeys now. I'm interested to see what new applications are emerging in optogenetics."

Another area of high interest that Goldberg highlights is the burgeoning understanding of the genetic basis of human disease, particularly in neuroscience, which he notes is particularly important with such difficult and complex diseases as schizophrenia.

"Something like sickle cell anemia is essentially based on one gene," he says, "but with schizophrenia we see that many different genes are involved, and how they interact is becoming an extraordinarily exciting area."

Also exciting is this year's speaker for the Dialogues Between Neuroscience and Society featured lecture—award-winning acress Glenn Close, whose talk is titled, "Bringing Change to Mind on Mental Illness." Close founded the website www.bringchange2mind.org to combat the stigma associated with mental illness and help the public discern fact from fiction so that more positive change can be brought to families struggling with mental illness.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Puzzle pieces spelling “DATA” alongside connected icons representing data analysis, storage, and reporting.
Earlier insight into analytical data can help laboratories recognize emerging trends and maintain method performance over time.
Top view of a laboratory researcher wearing green gloves and using a pipette to transfer liquid at a bench surrounded by other laboratory equipment.
​​​​​Repetitive pipetting can strain the hands, wrists, shoulders, and neck, making ergonomics an important part of efficient liquid handling.
A gloved hand holds two glass microscope slides containing pink-stained tissue sections in a laboratory setting.
See how advanced slide-based imaging connects tissue architecture with cellular detail across fluorescent and histological samples.